BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

756 related articles for article (PubMed ID: 28627110)

  • 1. Patient preferences for healthcare delivery through community pharmacy settings in the USA: A discrete choice study.
    Feehan M; Walsh M; Godin J; Sundwall D; Munger MA
    J Clin Pharm Ther; 2017 Dec; 42(6):738-749. PubMed ID: 28627110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacist's Demand for Optimal Primary Care Service Delivery in a Community Pharmacy: The OPTiPharm Study.
    Munger MA; Walsh M; Godin J; Feehan M
    Ann Pharmacother; 2017 Dec; 51(12):1069-1076. PubMed ID: 28737045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient preferences for community pharmacy asthma services: a discrete choice experiment.
    Naik-Panvelkar P; Armour C; Rose JM; Saini B
    Pharmacoeconomics; 2012 Oct; 30(10):961-76. PubMed ID: 22823521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferences for the delivery of community pharmacy services to help manage chronic conditions.
    Whitty JA; Kendall E; Sav A; Kelly F; McMillan SS; King MA; Wheeler AJ
    Res Social Adm Pharm; 2015; 11(2):197-215. PubMed ID: 25116938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing Minor Ailments; The Public's Preferences for Attributes of Community Pharmacies. A Discrete Choice Experiment.
    Porteous T; Ryan M; Bond C; Watson M; Watson V
    PLoS One; 2016; 11(3):e0152257. PubMed ID: 27031588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient preferences and willingness-to-pay for community pharmacy-led Medicare Part D consultation services: A discrete choice experiment.
    Murry LT; Viyurri B; Chapman CG; Witry MJ; Kennelty KA; Nayakankuppam D; Doucette WR; Urmie J
    Res Social Adm Pharm; 2023 May; 19(5):764-772. PubMed ID: 36710174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applying a whole systems lens to the general practice crisis: cross-sectional survey looking at usage of community pharmacy services in England by patients with long-term respiratory conditions.
    Hindi AMK; Schafheutle EI; Jacobs S
    BMJ Open; 2019 Nov; 9(11):e032310. PubMed ID: 31699746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A national survey exploring oral healthcare service provision across Australian community pharmacies.
    Freeman CR; Abdullah N; Ford PJ; Taing MW
    BMJ Open; 2017 Sep; 7(9):e017940. PubMed ID: 28963314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient preferences for objective quality metrics during community pharmacy selection: A discrete choice experiment.
    Patterson JA; Holdford DA; Harpe SE
    Res Social Adm Pharm; 2019 Jun; 15(6):641-649. PubMed ID: 30143466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacist Intentions to Prescribe Hormonal Contraception Following New Legislative Authority in California.
    Vu K; Rafie S; Grindlay K; Gutierrez H; Grossman D
    J Pharm Pract; 2019 Feb; 32(1):54-61. PubMed ID: 29096570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferences of community pharmacists for extended roles in primary care: a survey and discrete choice experiment.
    Scott A; Bond C; Inch J; Grant A
    Pharmacoeconomics; 2007; 25(9):783-92. PubMed ID: 17803336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients' preferences for an increased pharmacist role in the management of drug therapy.
    Tinelli M; Ryan M; Bond C
    Int J Pharm Pract; 2009 Oct; 17(5):275-82. PubMed ID: 20214269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients' value of asthma services in Australian pharmacies: the way ahead for asthma care.
    Naik-Panvelkar P; Armour C; Rose J; Saini B
    J Asthma; 2012 Apr; 49(3):310-6. PubMed ID: 22348432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacy patronage and service utilization: Associations with patient sociodemographic and health characteristics.
    Patterson JA; Holdford DA
    J Am Pharm Assoc (2003); 2019; 59(5):660-669.e2. PubMed ID: 31311757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying Community Pharmacist Preferences For Prescribing Services in Primary Care in New Zealand: A Discrete Choice Experiment.
    Raghunandan R; Howard K; Marra CA; Tordoff J; Smith A
    Appl Health Econ Health Policy; 2021 Mar; 19(2):253-266. PubMed ID: 33073328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferences heterogeneity of health care utilization of community residents in China: a stated preference discrete choice experiment.
    Jiang MZ; Fu Q; Xiong JY; Li XL; Jia EP; Peng YY; Shen X
    BMC Health Serv Res; 2020 May; 20(1):430. PubMed ID: 32423447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Audit of community pharmacists' prescribing interventions: Quality assessment of a newly reimbursed service.
    MacKeigan LD; Dolovich L; Petrovic B; MacCallum L; Bojarski EA; Pojskic N
    J Am Pharm Assoc (2003); 2018; 58(6):622-629. PubMed ID: 30190200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Care team perspectives on community pharmacy enhanced services.
    Fay AE; Ferreri SP; Shepherd G; Lundeen K; Tong GL; Pfeiffenberger T
    J Am Pharm Assoc (2003); 2018; 58(4S):S83-S88.e3. PubMed ID: 30006190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A needs assessment of community pharmacists for pharmacist specialization in Canada.
    Jorgenson D; Penm J; MacKinnon N; Smith J
    Int J Pharm Pract; 2017 Apr; 25(2):159-167. PubMed ID: 27488476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
    Wibowo Y; Parsons R; Sunderland B; Hughes J
    Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.